相似文献
1
Veterinary vaccines.
Biotechnol Adv. 1994;12(3):489-523. doi: 10.1016/0734-9750(94)90021-3.
2
Recent developments in veterinary vaccinology.
Vet J. 2005 Nov;170(3):289-99. doi: 10.1016/j.tvjl.2004.07.004.
3
Recent advances in veterinary vaccine adjuvants.
Int J Parasitol. 2003 May;33(5-6):469-78. doi: 10.1016/s0020-7519(03)00053-5.
4
Current status of veterinary vaccines.
Clin Microbiol Rev. 2007 Jul;20(3):489-510, table of contents. doi: 10.1128/CMR.00005-07.
5
New technology for improved vaccine safety and efficacy.
Vet Clin North Am Food Anim Pract. 2001 Nov;17(3):585-97, vii. doi: 10.1016/s0749-0720(15)30008-6.
6
Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
J Drug Target. 1998;6(4):243-9. doi: 10.3109/10611869808996832.
7
[Improvement of veterinary vaccines through the use of new adjuvants].
Tijdschr Diergeneeskd. 1991 May 15;116(10):508-12.
8
Novel antigen delivery systems.
World J Virol. 2015 Aug 12;4(3):156-68. doi: 10.5501/wjv.v4.i3.156.
9
Veterinary Products Committee working group report on feline and canine vaccination.
Vet Rec. 2002 Feb 2;150(5):126-34.
10
Diagnosis and prevention of equine infectious diseases: present status, potential, and challenges for the future.
Adv Vet Med. 1999;41:359-77. doi: 10.1016/s0065-3519(99)80027-5.
本文引用的文献
1
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.
Biotechnology (N Y). 1986;4(7):637-641. doi: 10.1038/nbt0786-637.
2
The ISCOM: an immunostimulating complex.
Immunol Today. 1987;8(11):333-8. doi: 10.1016/0167-5699(87)90008-9.
3
Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia.
Immunol Today. 1984 Aug;5(8):240-4. doi: 10.1016/0167-5699(84)90097-5.
4
5
Heterologous protection against influenza by injection of DNA encoding a viral protein.
Science. 1993 Mar 19;259(5102):1745-9. doi: 10.1126/science.8456302.
6
Selection of bacterial virulence genes that are specifically induced in host tissues.
Science. 1993 Jan 29;259(5095):686-8. doi: 10.1126/science.8430319.
7
Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.
Infect Immun. 1993 Feb;61(2):565-72. doi: 10.1128/iai.61.2.565-572.1993.
8
Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
J Gen Virol. 1993 Sep;74 ( Pt 9):1995-9. doi: 10.1099/0022-1317-74-9-1995.
9
Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.
Vaccine. 1993;11(6):629-36. doi: 10.1016/0264-410x(93)90308-k.
10
Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5.
Virology. 1993 Jul;195(1):42-50. doi: 10.1006/viro.1993.1344.
Zotero 插件